Excited to share that our paper on developing a novel conditional event-free survival (cEFS) tool in DLBCL has finally been published!
onlinelibrary.wiley.com/share/author/J…
onlinelibrary.wiley.com/share/author/J…
Danny Luan
@DannyLuan6
Current a first year hemonc fellow at @WCMHemOncFellow. Formerly medical student and internal medicine resident at @WeillCornell. Opinions = my own.
93 Following 100 Followers 43 Posts
Latest posts 5
Finally published in print! Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma @RShouval @KRejeski ashpublications.org/blood/article/…
ashpublications.org Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma Key PointsEarlier infusion time of CAR T-cell therapy was independently associated with improved PFS in large B-cell lymphoma.These findings support the pr Yet another example of early time-of-day immunotherapy leading to improved clinical outcomes, this time in NSCLC! nature.com/articles/s4159…
Excited to share the online-first edition of our recent study looking at time of day and CAR-T outcomes in LBCL.
Across 7 large centers, we found a robust PFS benefit among early infusions. A multinational effort supervised by @RShouval and @KRejeski
ashpublications.org/blood/article-…
Across 7 large centers, we found a robust PFS benefit among early infusions. A multinational effort supervised by @RShouval and @KRejeski
ashpublications.org/blood/article-…
ashpublications.org Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma Key PointsEarlier infusion time of CAR T-cell therapy was independently associated with improved PFS in large B-cell lymphoma.These findings support the pr My cofellows at @WCMHemOncFellow bridging all 3 years! Can’t imagine a better group of colleagues for another trip to #ASH2025
